Healthcare Triangle vs Sophia Genetics SA
Sophia Genetics SA is the larger business, with $77.3m of revenue in fiscal 2025 against $13.9m for Healthcare Triangle (5.6 times as much). Healthcare Triangle grew faster (18.8% against 18.6%). Healthcare Triangle kept more of each dollar of sales as profit: a net margin of -68.2% against -102.2%.
| Latest fiscal year | Healthcare TriangleHCTI, 2025 | Sophia Genetics SASOPH, 2025 |
|---|---|---|
| Revenue | $13.9m | $77.3m |
| Revenue growth | 18.8% | 18.6% |
| Net income | −$9.5m | −$79.0m |
| Operating margin | — | -91.8% |
| Net margin | -68.2% | -102.2% |
| Return on equity | — | -110.0% |
| Free cash flow | −$16.5m | −$36.5m |
| Cash | $7.6m | $70.3m |
| Total debt | $10.5m | $47.7m |
| Debt to equity | — | 101.2% |
| Dividend per share | — | — |
| Dividend yield | — | — |
| Share buybacks | — | — |
| Employees | — | — |
| Market value | $10.4m | $460m |
| Price vs our value range | — | — |
| Moat score | — | — |
| Insider trades, 12 months | 0 buys, 0 sales | 1 buys, 150 sales |